Table 1.
Baseline characteristics of subjects

Variables NMIBC (n=163)
Age, yrs (mean) 63.2 ± 13.8
Gender, no. of patients (%) Male 133 (81.6)
Female 30 (18.4)
No. of tumors (%) Single 96 (58.9)
Multiple 67 (41.1)
Tumor size (%) <3 cm 89 (54.6)
≥3 cm 74 (45.4)
Grade, no. of patients (%) G1 53 (32.5)
G2 86 (52.8)
G3 24 (14.7)
T Stage Ta 61 (37.4)
T1 102 (62.6)
Intravesical treatment, no. of patients (%) No 83 (50.9)
Yes 80 (49.1)
Recurrence-free survival, months (median) 43.9 (6.1~171.5)
Recurrence, no. of patients (%) No 107 (65.6)
Yes 56 (34.4)
Progression free survival, months (median) 52.3 (6.6~164.9)
Progression, no. of patients (%) No 145 (89.0)
Yes 18 (11.0)
NMIBC, non-muscle invasive bladder cancer.